# Mary Edmondson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mary-edmondson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,337 |
| Field | Genetic Neurodegenerative Diseases |
| h-index | 19 |
| i10-index | 24 |
| OpenAlex ID | https://openalex.org/A5046909063 |
| Works | 45 |

## Researcher papers

- [Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial](https://scholariq.org/papers/azithromycin-in-patients-admitted-to-hospital-with-covid-19-recovery-a/)
- [Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial](https://scholariq.org/papers/convalescent-plasma-in-patients-admitted-to-hospital-with-covid-19-recovery-a/)
- [Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease](https://scholariq.org/papers/effect-of-deutetrabenazine-on-chorea-among-patients-with-huntington-disease/)
- [Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial](https://scholariq.org/papers/casirivimab-and-imdevimab-in-patients-admitted-to-hospital-with-covid-19/)
- [Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis](https://scholariq.org/papers/baricitinib-in-patients-admitted-to-hospital-with-covid-19-recovery-a-randomised/)
- [Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial](https://scholariq.org/papers/aspirin-in-patients-admitted-to-hospital-with-covid-19-recovery-a-randomised/)
- [Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial](https://scholariq.org/papers/higher-dose-corticosteroids-in-patients-admitted-to-hospital-with-covid-19-who/)
- [Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders](https://scholariq.org/papers/clinical-management-of-neuropsychiatric-symptoms-of-huntington-disease-expert/)
- [An International Survey-based Algorithm for the Pharmacologic Treatment of Irritability in Huntington's Disease](https://scholariq.org/papers/an-international-survey-based-algorithm-for-the-pharmacologic-treatment-of/)
- [Caregiver burden in atypical dementias: comparing frontotemporal dementia, Creutzfeldt–Jakob disease, and Alzheimer's disease](https://scholariq.org/papers/caregiver-burden-in-atypical-dementias-comparing-frontotemporal-dementia/)

## Researcher topics

- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.